Mercy Abuaba, NP
Primary Care · Aurora, CONPI 1336687524
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 49 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 12.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $424 and has fallen 71.9% since, to $119 in 2025.
Across 49 payments — averaging $20.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$126
- Sumitomo Pharma America, Inc.$115
- Johnson & Johnson$103
- AbbVie$94
- Dexcom, Inc.$49
- Aimmune Therapeutics, Inc.$48
- plus $447 from 17 others
What the payments were for
- Food & beverage$981100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 7 | $126 |
| Sumitomo Pharma America, Inc. | 6 | $115 |
| Johnson & Johnson | 5 | $103 |
| AbbVie | 4 | $94 |
| Dexcom, Inc. | 2 | $49 |
| Aimmune Therapeutics, Inc. | 2 | $48 |
| Novo Nordisk | 3 | $47 |
| Lundbeck LLC | 2 | $43 |
| Shield Therapeutics Inc | 1 | $42 |
| Otsuka America Pharmaceutical, Inc. | 2 | $38 |
| Amgen | 2 | $37 |
| Exact Sciences | 2 | $33 |
| GSK | 1 | $33 |
| Acadia Pharmaceuticals Inc | 1 | $22 |
| Novartis | 1 | $21 |
| Neurocrine Biosciences, Inc. | 1 | $20 |
| Inogen, Inc. | 1 | $19 |
| Nevro Corp. | 1 | $18 |
| Merck | 1 | $17 |
| Pfizer | 1 | $16 |
| Hologic Sales And Service, LLC | 1 | $14 |
| Bayer | 1 | $14 |
| Philips North America LLC | 1 | $14 |
How this compares
$981 in reported general payments places this provider in the 75th percentile of 112 primary care providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Omeprazole | 23 | $497 |
| Atorvastatin Calcium | 32 | $390 |
| Levothyroxine Sodium | 28 | $272 |
| Tamsulosin Hcl | 19 | $263 |
| Gabapentin | 11 | $190 |
| Amlodipine Besylate | 21 | $169 |
| Montelukast Sodium | 12 | $113 |
| Losartan Potassium | 15 | $102 |
| Trazodone Hcl | 13 | $72 |
| Simvastatin | 12 | $68 |
| Metformin Hcl | 12 | $58 |
Paid to pharmacies, not to this prescriber.
Other primary care in Aurora
- Diana Rodriguez OrtizAurora$2K
- Jenelynn KimbleAurora$464
- Matthew WernerAurora$356
- Kateri ScheidtAurora$320
- Allison PageAurora$287
- Devon WallAurora$276
- Lily JuanAurora$217
- Lorri PhippsAurora$185
- Laura CarlsenLittleton$22K
- Kendra PayneCastle Rock$22K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.